Design Therapeutics, Inc. SEC filings DSGN
Design Therapeutics, Inc. has 268 filings in SEC EDGAR's recent list, going back to Mar 20, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 18, 2025 | — |
| 144 | Notice of proposed sale | Nov 18, 2025 | — |
| 144 | Notice of proposed sale | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 12, 2025 | — |
| 144 | Notice of proposed sale | Nov 7, 2025 | — |
| 4 | Insider transaction | Sep 10, 2025 | Sep 9, 2025 |
| 3 | Initial insider ownership | Sep 10, 2025 | Sep 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 28, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 13, 2025 |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 1, 2025 |
| 3 | Initial insider ownership | May 23, 2025 | Apr 16, 2025 |
| 3 | Initial insider ownership | Feb 7, 2025 | Oct 1, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 18, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 13, 2024 | — |
| 4 | Insider transaction | Aug 12, 2024 | Aug 9, 2024 |
| 144 | Notice of proposed sale | Aug 9, 2024 | — |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 22, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 25, 2024 |
| 3 | Initial insider ownership | Mar 20, 2024 | Mar 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 23, 2024 | — |
| 4 | Insider transaction | Jan 5, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2023 | — |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 7, 2023 | — |
| 4/A | Form 4/a submission | Sep 6, 2023 | Mar 30, 2021 |
| 4 | Insider transaction | Sep 5, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Aug 30, 2023 | Aug 29, 2023 |
| 4 | Insider transaction | Aug 30, 2023 | Aug 28, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | May 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Apr 3, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2023 | — |
| 4 | Insider transaction | Feb 3, 2023 | Feb 1, 2023 |
| 4 | Insider transaction | Feb 3, 2023 | Feb 1, 2023 |
| 4 | Insider transaction | Feb 3, 2023 | Feb 1, 2023 |
| 4 | Insider transaction | Feb 3, 2023 | Feb 1, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 3, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 22, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 22, 2022 | — |
| 4 | Insider transaction | Dec 21, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 12, 2022 | Dec 9, 2022 |
| SC 13G | Ownership over 5% (passive) | Oct 13, 2022 | — |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 16, 2022 | Jun 15, 2022 |
| SC 13D | Ownership over 5% (active) | Mar 31, 2022 | — |
| 4 | Insider transaction | Mar 22, 2022 | Mar 21, 2022 |
| 4 | Insider transaction | Mar 22, 2022 | Mar 18, 2022 |
| 4 | Insider transaction | Mar 18, 2022 | Mar 16, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| 4 | Insider transaction | Feb 2, 2022 | Feb 1, 2022 |
| 4 | Insider transaction | Feb 2, 2022 | Feb 1, 2022 |
| 4 | Insider transaction | Feb 2, 2022 | Feb 1, 2022 |
| 4 | Insider transaction | Feb 2, 2022 | Feb 1, 2022 |
| 4 | Insider transaction | Oct 4, 2021 | Oct 1, 2021 |
| 3 | Initial insider ownership | Sep 20, 2021 | Sep 13, 2021 |
| 4 | Insider transaction | Sep 2, 2021 | Aug 31, 2021 |
| 3 | Initial insider ownership | Aug 17, 2021 | Aug 13, 2021 |
| 4 | Insider transaction | Jun 16, 2021 | Jun 15, 2021 |
| 3 | Initial insider ownership | Jun 16, 2021 | Jun 15, 2021 |
| 4 | Insider transaction | Jun 16, 2021 | Jun 15, 2021 |
| 3 | Initial insider ownership | Jun 16, 2021 | Jun 15, 2021 |
| SC 13G | Ownership over 5% (passive) | Apr 9, 2021 | — |
| SC 13D | Ownership over 5% (active) | Apr 9, 2021 | — |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2020 |
| 4 | Insider transaction | Apr 1, 2021 | Mar 30, 2021 |
| 3/A | Form 3/a submission | Mar 30, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 29, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 29, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 29, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 29, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 29, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
| 3 | Initial insider ownership | Mar 25, 2021 | Mar 25, 2021 |
Showing 155 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DSGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1807120
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.